Comprehensive review found smoking marijuana causes bronchitis but likely not lung cancer | Research

The takeaway

A review of inhaled marijuana effects found it causes short-term bronchodilation and long-term chronic bronchitis symptoms, but most studies have not found it to be a significant lung cancer risk factor.

People who smoke marijuana, pulmonologists, and harm reduction advocates comparing consumption methods.

No significant lung cancer risk despite procarcinogenic smoke components

What the researchers found

Smoking marijuana produces short-term bronchodilation in healthy subjects and asthmatics. Long-term effects include chronic bronchitis symptoms (cough, sputum, wheezing) but no significant decrease in FEV1. Most studies have failed to link marijuana smoking to lung cancer despite procarcinogenic smoke components. Pneumonia risk was not increased in immunocompetent users.

Why it matters

With marijuana smoking still the most common consumption method, understanding its respiratory effects helps users and clinicians make informed decisions about consumption methods and health monitoring.

The numbers in context

No significant decrease in FEV1 from marijuana smoking. Mild reductions in FEV1/FVC ratio. Increase in forced vital capacity and other lung volumes. Variable effects on diffusing capacity. No consistent lung cancer association despite procarcinogenic components.

How the study worked

Narrative review of the literature on inhaled marijuana effects on lung health, covering short-term bronchodilation, chronic respiratory symptoms, lung function changes, lung cancer risk, asthma association, and pneumonia risk.

What this study cannot tell us

Narrative review without systematic search methodology. Many included studies had limited follow-up periods. Quantifying marijuana exposure is inherently difficult (variable potency, inhalation technique).

How to read the evidence

Moderate: comprehensive review by recognized experts, but narrative rather than systematic methodology.

When this study was published

Published in 2022.

The bigger picture

The disconnect between marijuana smoke containing carcinogens and the lack of increased lung cancer risk is one of the most puzzling findings in cannabis research. THC's immunomodulatory properties may play a protective role.

Questions still open

Why does marijuana smoking not increase lung cancer risk despite containing carcinogens? Does vaping marijuana carry the same or different respiratory risks? Would longer follow-up studies reveal different outcomes?

Common questions

Does marijuana smoking damage the lungs?

It causes chronic bronchitis symptoms (cough, sputum, wheezing) and some changes in lung function measurements, but it has not been consistently linked to the major lung diseases caused by tobacco smoking.

Why does marijuana smoke not cause lung cancer?

This remains unclear. Despite containing many of the same carcinogens as tobacco smoke, most studies have failed to find a significant lung cancer risk. THC's anti-inflammatory and potentially anti-tumor properties may play a role.

Is vaping marijuana safer for the lungs?

Vaping has been associated with cases of acute severe lung injury (EVALI). The review notes that while vaping is increasing as a consumption method, its long-term respiratory effects are less well-studied than smoking.

Read the original research

Inhaled Marijuana and the Lung.

The journal of allergy and clinical immunology. In practice, 10(11), 2822-2829

View on PubMed ↗Publisher’s paper ↗

Citation

Tashkin, Donald P; Tan, Wan-Cheng. (2022). Inhaled Marijuana and the Lung.. The journal of allergy and clinical immunology. In practice, 10(11), 2822-2829. https://doi.org/10.1016/j.jaip.2022.05.009